335155-20-9
Catalog No.:AA01KL67

335155-20-9 | 2-Methyl-4-(2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)benzonitrile

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
2 weeks  
$78.00   $55.00
- +
250mg
97%
2 weeks  
$126.00   $88.00
- +
1g
97%
2 weeks  
$366.00   $256.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01KL67
Chemical Name:
2-Methyl-4-(2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)benzonitrile
CAS Number:
335155-20-9
Molecular Formula:
C19H18N2O
Molecular Weight:
290.3590
SMILES:
N#Cc1ccc(cc1C)C(=O)N1CCCCc2c1cccc2
Properties

Downstream Synthesis Route

[1]Patent:WO2006/18443,2006,A1.Locationinpatent:Page/Pagecolumn23-24

[2]Patent:US6664249,2003,B1.Locationinpatent:Pagecolumn12

[3]Patent:US2004/38962,2004,A1

[4]Patent:US2004/38962,2004,A1

[5]Patent:US2004/38962,2004,A1

[6]JournalofMedicinalChemistry,2008,vol.51,p.8124-8134

[1]CurrentPatentAssignee:VANTIALIMITED-US6664249,2003,B1Locationinpatent:Pagecolumn12

[2]CurrentPatentAssignee:VANTIALIMITED-US2004/38962,2004,A1

[3]CurrentPatentAssignee:VANTIALIMITED-US2004/38962,2004,A1

[1]Patent:US2003/87892,2003,A1

[1]Locationinpatent:experimentalpartFrantz,Marie-Céline;Rodrigo,Jordi;Boudier,Laure;Durroux,Thierry;Mouillac,Bernard;Hibert,Marcel[JournalofMedicinalChemistry,2010,vol.53,#4,p.1546-1562]

[2]CurrentPatentAssignee:VANTIALIMITED-WO2006/18443,2006,A1Locationinpatent:Page/Pagecolumn24

[3]Locationinpatent:schemeortableYea,ChristopherM.;Allan,ChristineE.;Ashworth,DoreenM.;Barnett,James;Baxter,AndyJ.;Broadbridge,JaniceD.;Franklin,RichardJ.;Hampton,SallyL.;Hudson,Peter;Horton,JohnA.;Jenkins,PaulD.;Penson,AndyM.;Pitt,GaryR.W.;Rivière,Pierre;Robson,PeterA.;Rooker,DavidP.;Semple,Graeme;Sheppard,Andy;Haigh,RobertM.;Roe,MichaelB.[JournalofMedicinalChemistry,2008,vol.51,#24,p.8124-8134]

[1]Locationinpatent:experimentalpartYea,ChristopherM.;Allan,ChristineE.;Ashworth,DoreenM.;Barnett,James;Baxter,AndyJ.;Broadbridge,JaniceD.;Franklin,RichardJ.;Hampton,SallyL.;Hudson,Peter;Horton,JohnA.;Jenkins,PaulD.;Penson,AndyM.;Pitt,GaryR.W.;Rivière,Pierre;Robson,PeterA.;Rooker,DavidP.;Semple,Graeme;Sheppard,Andy;Haigh,RobertM.;Roe,MichaelB.[JournalofMedicinalChemistry,2008,vol.51,#24,p.8124-8134]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 335155-20-9
Building Blocks
More >
Tags:335155-20-9 Molecular Formula|335155-20-9 MDL|335155-20-9 SMILES|335155-20-9 2-Methyl-4-(2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)benzonitrile
Catalog No.: AA01KL67
335155-20-9
335155-20-9 | 2-Methyl-4-(2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)benzonitrile
Pack Size: 100mg
Purity: 97%
2 weeks
$78.00 $55.00
Pack Size: 250mg
Purity: 97%
2 weeks
$126.00 $88.00
Pack Size: 1g
Purity: 97%
2 weeks
$366.00 $256.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01KL67
Chemical Name: 2-Methyl-4-(2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)benzonitrile
CAS Number: 335155-20-9
Molecular Formula: C19H18N2O
Molecular Weight: 290.3590
SMILES: N#Cc1ccc(cc1C)C(=O)N1CCCCc2c1cccc2
Properties
Downstream Synthesis Route
1701-57-1    73831-13-7    335155-20-9 

[1]Patent:WO2006/18443,2006,A1.Locationinpatent:Page/Pagecolumn23-24

[2]Patent:US6664249,2003,B1.Locationinpatent:Pagecolumn12

[3]Patent:US2004/38962,2004,A1

[4]Patent:US2004/38962,2004,A1

[5]Patent:US2004/38962,2004,A1

[6]JournalofMedicinalChemistry,2008,vol.51,p.8124-8134

335155-20-9    335155-21-0 

[1]CurrentPatentAssignee:VANTIALIMITED-US6664249,2003,B1Locationinpatent:Pagecolumn12

[2]CurrentPatentAssignee:VANTIALIMITED-US2004/38962,2004,A1

[3]CurrentPatentAssignee:VANTIALIMITED-US2004/38962,2004,A1

1122-58-3    1701-57-1    73831-13-7    335155-20-9 

[1]Patent:US2003/87892,2003,A1

335155-20-9    736127-06-3 

[1]Locationinpatent:experimentalpartFrantz,Marie-Céline;Rodrigo,Jordi;Boudier,Laure;Durroux,Thierry;Mouillac,Bernard;Hibert,Marcel[JournalofMedicinalChemistry,2010,vol.53,#4,p.1546-1562]

[2]CurrentPatentAssignee:VANTIALIMITED-WO2006/18443,2006,A1Locationinpatent:Page/Pagecolumn24

[3]Locationinpatent:schemeortableYea,ChristopherM.;Allan,ChristineE.;Ashworth,DoreenM.;Barnett,James;Baxter,AndyJ.;Broadbridge,JaniceD.;Franklin,RichardJ.;Hampton,SallyL.;Hudson,Peter;Horton,JohnA.;Jenkins,PaulD.;Penson,AndyM.;Pitt,GaryR.W.;Rivière,Pierre;Robson,PeterA.;Rooker,DavidP.;Semple,Graeme;Sheppard,Andy;Haigh,RobertM.;Roe,MichaelB.[JournalofMedicinalChemistry,2008,vol.51,#24,p.8124-8134]

335155-20-9    1092844-49-9 

[1]Locationinpatent:experimentalpartYea,ChristopherM.;Allan,ChristineE.;Ashworth,DoreenM.;Barnett,James;Baxter,AndyJ.;Broadbridge,JaniceD.;Franklin,RichardJ.;Hampton,SallyL.;Hudson,Peter;Horton,JohnA.;Jenkins,PaulD.;Penson,AndyM.;Pitt,GaryR.W.;Rivière,Pierre;Robson,PeterA.;Rooker,DavidP.;Semple,Graeme;Sheppard,Andy;Haigh,RobertM.;Roe,MichaelB.[JournalofMedicinalChemistry,2008,vol.51,#24,p.8124-8134]

Building Blocks More >
Submit
© 2017 AA BLOCKS, INC. All rights reserved.